Background: An expanded CAG trinucleotide repeat is the genetic trigger of neuronal degeneration in Huntington's disease (HD), but its mode of action has yet to be discovered. The sequence of the HD gene places the CAG repeat near the 5' end in a region where it may be translated as a variable polyglutamine segment in the protein product, huntingtin. Materials and Methods: Antisera directed at amino acid stretches predicted by the DNA sequence upstream and downstream of the CAG repeat were used in Western blot and immunohistochemical analyses to examine huntingtin expression from the normal and the HD allele in lymphoblastoid cells and postmortem brain tissue.
INTRODUCTION
Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by progressive choreic movements, psychiatric changes, and cognitive decline (1, 2) . These manifestations result from neuronal cell death, principally in the basal ganglia, where medium spiny neurons are the most vulnerable targets. Within the neostriatum, cell loss follows a characteristic gradient proceeding along the postero-anterior, dorsoventral, and medio-lateral axes (3) . HD affects about 1 in 10,000 individuals in the United States and is caused by a dominant genetic defect that was mapped to 4pl6.3 by linkage analysis (4) and recently identified by location cloning (5) .
Virtually all individuals with authenticated HD possess an unstable, expanded CAG trinucleotide repeat (reviewed in Refs. 6 and 7). In normal individuals, this repeat is polymorphic, varying from 6 to 34 trinucleotide units, and is inherited in a mendelian fashion. By contrast, the CAG repeat on disease chromosomes comprises 37 to more than 120 units, and shows a mutation rate approaching 1 through meiotic transmission. CAG repeat length is inversely correlated with age at onset of both neurologic and psychiatric symptoms, and with age at death. Most individuals show onset in mid-life due to repeat lengths in the range of 40-50 units, with a minority displaying either juvenile onset (typically >60 units) or onset very late in life (usually 37-40 units).
The mechanism whereby CAG repeat expansion causes neuronal death has not been established, but a number of observations favor an effect at the level of huntingtin, the HD gene's protein product (8) . Huntingtin mRNA is not expressed exclusively or even preferentially in the affected brain regions, but is present in all tissues tested (9) (10) (11) . RNA is produced from both normal and disease alleles, and contains the CAG repeat segment. Thus, the expanded CAG repeat is most likely to affect production of huntingtin from the disease allele, or to alter its structure, localization, or activity (5, 6, 12) . We have used antisera directed against potential translated sequences both upstream and downstream of the CAG repeat to investigate the expression of huntingtin from normal and HD alleles. Our data establish that the CAG segment is indeed translated into a predicted polymorphic polyglutamine stretch near the N terminus of huntingtin. The (13) .
Cultured Lymphoblast Cell Lines and
Postmortem Human Brain Tissue Lymphoblast cell lines from HD families of various ethnic backgrounds used for genetic linkage, and disequilibrium studies (14, 15) have been established (16) 1 mM DTT, 0.1% leupeptin, and 0.1 % aprotinin to produce the soluble nuclear fraction (N). The postnuclear supernatant (PN), was fractionated by centrifugation at 100,000 x g to produce the 100,000 X g supernatant, SiO0 (S), and the 100,000 X g pellet P100 (P).
Western Blotting
Extracts (-200 expressed in E. coli as a fusion with glutathione-S-transferase (GST). No other specific lower molecular weight proteins were detected in these analyses and use of multiple antisera against the same blot did not reveal additional specific bands (data not shown), supporting the view that the discrete band detected at -350 kD by all of these antisera is huntingtin. This notion is also corroborated by immunoprecipitation of huntingtin from 35S-labeled lymphoblast extracts using HP1 and HF1 (data not shown). The fact that huntingtin is detected using antisera directed against predicted epitopes both upstream and downstream of the CAG repeat indicates that the trinucleotide segment is translated in a frame predicted to produce a lengthy stretch of polyglutamine.
The HD Mutation Does Not Eliminate Huntingtin Expression Huntington's disease displays a completely dominant clinical phenotype, as evidenced by a number of individuals who are homozygous for the disease allele (22, 23) . Lymphoblast cell lines from such individuals make it possible to demonstrate directly expression of huntingtin from the mutant allele. For example, in Fig. 1C, HP1 , HP12, and HF1 all detect huntingtin in an HD homozygote with CAG repeat lengths of 41 and 54 on the two disease chromosomes.
Interestingly, not only is huntingtin produced from the HD allele, but the HD huntingtin can also be distinguished from normal huntingtin based on its electrophoretic mobility. For example, Fig. 1 To confirm our presumption that the larger of the two huntingtin bands derives from the HD allele, while the smaller is expressed from the normal allele, we performed the analysis shown in Figure 2 . Segregation of the HD and normal alleles in a family previously reported to contain HD homozygotes (22) Figure 3A shows typical results for freshly collected caudate/putamen, temporal cortex and frontal cortex, all of which reveal the same size band seen in normal lymphoblasts. The two different isoforms of huntingtin in an HD heterozygote are also detectable in freshly collected postmortem brain tissue (Fig. 3B ).
Huntingtin Is a Primarily Cytosolic Protein
We have performed cell fractionation experiments to determine whether the structural alteration in HD huntingtin affects the cellular localization of the protein. Figure 4A shows an example of Western blot analysis of cell fractions produced from normal and HD lymphoblasts by differential centrifugation. The cell fractions were tested for huntingtin and for the distribution of several control proteins (Fig. 4B) . As expected, HD huntingtin migrated more slowly than normal huntingtin.
Huntingtin is found primarily in the cytosol (S100) fraction when fractionation of either normal or HD homozygous lymphoblasts is performed in the absence of added salt or detergent. Very little protein is detected in the nuclear fractions (including both nucleosol and nuclear pellet preparations), even upon long exposures of the blots. A small proportion of huntingtin does pellet from the cytoplasmic fraction at 100,000 x g (P100 fraction). This minor component can be shifted into the S100 cytosolic fraction by frac- tionation in the presence of increasing salt concentrations, suggesting that its association with a pelletable element is relatively weak. No differences were observed between normal and HD homozygous cells, indicating that the fractionation characteristics of huntingtin are not altered by the presence of the HD defect.
The cytoplasmic location of huntingtin was confirmed by immunohistochemical analysis of normal and HD tissues. A preliminary survey of our antisera indicated that the preimmune sera did not yield significant staining and that, of the immune sera, only HF1 exhibited reproducible staining. Because of the reactivity of HF1 serum with the nonspecific 200-kD band on Western blots (Fig. IA and B) , we tested the huntingtin specificity of the immunohistochemical staining by preabsorption with immunogen. Figure 5A shows a typical example of the distribution achieved in frontal cortex (in this case from an HD heterozygote). Both neuronal cell bodies and neuropil are stained by anti-huntingtin antisera, (24), and the bottom panel the results with a monoclonal antibody directed at pERKI (Transduction Laboratories), a 44-kD plasma membrane associated protein that is detected in the P fraction (25) . The band at -45 kD is probably a phosphorylated form of ERKI that is also recognized by this monoclonal. In separate experiments (not shown), similar Western blots were probed with polyclonal rabbit antisera against ornithine aminotransferase (OAT), a mitochondrial protein (26) that was detected in the P fraction and neurofibromin (27) , a cytoplasmic protein that can associate with microtubules that was found in both the P and S fractions (28) .
and this signal is effectively removed by preabsorption (Fig. SB) analysis. The basis for the disproportionate contribution of additional glutamines in reducing the electrophoretic mobility of huntingtin is not obvious, but this phenomenon has also been observed for smaller proteins (H. T. M. Timmers, personal communication). Consequently, additional investigation might lead to a method of separating huntingtin products from alleles differing by fewer than 20 CAG units.
Our investigations also demonstrate clearly that both normal and HD isoforms of huntingtin are cytoplasmic proteins. The only previous investigation of huntingtin's cellular location was an immunohistochemical analysis using a single C-terminal anti-peptide antiserum (29) . This yielded variable results, staining either exclusively cytoplasm in most cells or both cytoplasm and nucleus in lymphoblasts and neurons. Both our Western blot and immunohistochemical analyses failed to corroborate the suggestion of nuclear localization, implying that the previously reported variable nuclear staining may have been due to specific conditions that allowed shuttling of the protein or at least its C-terminal portion into the nucleus in some cells, or may have been spurious. Our detection of huntingtin exclusively in the cytoplasm of both normal and HD cells indicates that the expanded polyglutamine segment does not to alter the protein's cellular compartment. However, more detailed studies at the EM level could conceivably reveal regional differences in distribution of normal and HD huntingtin within the cytoplasm.
The translation of the CAG repeat into a polyglutamine segment in huntingtin strengthens the view that the defect acts at the protein level. Possible mechanisms include inappropriate cellular expression or intracellular localization, increased activity, a dominant negative effect, or a gain of function. Any hypothesis ultimately must also account for the specificity of cell death and the strong correlation between repeat length and disease severity.
Neither HD mRNA in situ hybridization studies nor preliminary immunohistochemical analysis have suggested a flagrant abnormality in the pattern of huntingtin expression in HD brain (9) (10) (11) 29) , although more detailed studies in a variety of cells and tissues during development might still reveal significant differences. Both increased activity of HD huntingtin and a dominant negative effect of the mutation represent hypotheses that cannot be tested directly, since no function has yet been ascribed to the protein. The gain-of-function scenario, which is particu-larly attractive, could involve the formation of a toxic byproduct from HD huntingtin, or a novel interaction with another cytoplasmic component. The latter would explain the cellular specificity of the pathogenesis if the abnormal interaction occurred with a protein peculiar to striatal neurons.
An important difference between the gainof-function hypothesis and the other potential models is that in the former, the pathogenic mechanism might operate without any detrimental effects on huntingtin's normal activity. For example, this contrasts directly with the dominant negative hypothesis which presumes a loss of huntingtin's activity and places a premium on discovering the normal role for this protein. These two opposing mechanisms may be distinguished by manipulation of the mouse Hdh gene, either to inactivate it or to introduce an expanded CAG segment. It is hoped that at least one of the two will yield an accurate genetic model for dissecting the steps by which production of HD huntingtin leads to specific neuronal death.
